Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris(®)) in Pituitary-Suppressed Healthy Women

This was a Phase I, open-label, randomized, two-period, two-sequence crossover study [ClinicalTrials.gov NCT02317809 (https://www.clinicaltrials.gov/ct2/show/NCT02317809); EudraCT 2014-003506-32] assessing the bioequivalence of the liquid and freeze-dried formulations of fixed-dose, fixed-ratio (2:1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagchus, Wilhelmina, Yalkinoglu, Özkan, Wolna, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768635/
https://www.ncbi.nlm.nih.gov/pubmed/29375477
http://dx.doi.org/10.3389/fendo.2017.00371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768635/
https://www.ncbi.nlm.nih.gov/pubmed/29375477
http://dx.doi.org/10.3389/fendo.2017.00371

Ejemplares similares